Back
EU Parliament Roundtable - IBBIS
webCredibility Rating
4/5
High(4)High quality. Established institution or organization with editorial oversight and accountability.
Rating inherited from publication venue: International Biosecurity and Biosafety Initiative
Published by IBBIS, an organization promoting biosecurity screening standards; relevant to AI safety discussions around biological risks, dual-use research governance, and how international policy bodies approach catastrophic risk management in emerging technologies.
Metadata
Importance: 38/100organizational reportnews
Summary
This resource covers an IBBIS-associated EU Parliament roundtable discussion focused on balancing biosecurity measures with maintaining Europe's competitiveness in biotechnology. It likely addresses policy frameworks for dual-use research oversight, biosecurity screening, and how international coordination can manage biological risks without stifling innovation.
Key Points
- •Examines the tension between biosecurity requirements and biotechnology competitiveness in the EU context
- •Draws on EU Parliament roundtable discussions involving policymakers and biosecurity experts
- •IBBIS (International Biosecurity and Biosafety Initiative for Science) perspective on governance frameworks
- •Addresses dual-use research concerns and the need for international coordination on biosecurity screening
- •Relevant to AI safety insofar as AI-enabled bioweapons and biosecurity governance intersect
Cited by 1 page
| Page | Type | Quality |
|---|---|---|
| IBBIS (International Biosecurity and Biosafety Initiative for Science) | Organization | 60.0 |
Cached Content Preview
HTTP 200Fetched Mar 20, 20265 KB
- [About](https://ibbis.bio/about/)
- [People](https://ibbis.bio/about/people/)
- [Careers](https://ibbis.bio/about/careers/)
- [News](https://ibbis.bio/news/)
- [Our Work](https://ibbis.bio/our-work/)
- [Commec Sequence Screening](https://ibbis.bio/our-work/common-mechanism/)
- [Customer Screening](https://ibbis.bio/our-work/customer-screening/)
- [Global Synthesis Map](https://ibbis.bio/our-work/global-dna-synthesis-map/)
- [International Standards](https://ibbis.bio/our-work/international-screening-standards/)
- [Sequence Biosecurity Standards](https://ibbis.bio/our-work/sequence-biosecurity-standards/)
- [Vulnerability Disclosure](https://ibbis.bio/our-work/vulnerability-disclosure/)
- [Contact](https://ibbis.bio/contact/)
[](https://ibbis.bio/)
- [About](https://ibbis.bio/about/)
- [People](https://ibbis.bio/about/people/)
- [Careers](https://ibbis.bio/about/careers/)
- [News](https://ibbis.bio/news/)
- [Our Work](https://ibbis.bio/our-work/)
- [Commec Sequence Screening](https://ibbis.bio/our-work/common-mechanism/)
- [Customer Screening](https://ibbis.bio/our-work/customer-screening/)
- [Global Synthesis Map](https://ibbis.bio/our-work/global-dna-synthesis-map/)
- [International Standards](https://ibbis.bio/our-work/international-screening-standards/)
- [Sequence Biosecurity Standards](https://ibbis.bio/our-work/sequence-biosecurity-standards/)
- [Vulnerability Disclosure](https://ibbis.bio/our-work/vulnerability-disclosure/)
- [Contact](https://ibbis.bio/contact/)
Security and Competitiveness in Biotech: Insights from EU parliament roundtable
IBBIS, the [Pandemic Action Network](https://www.pandemicactionnetwork.org/), [Pour Demain](https://www.pourdemain.ngo/), and [RAND Europe](https://www.rand.org/randeurope.html) joined forces to co-host a high-level roundtable at the European Parliament, in collaboration with Member of the European Parliament (MEP) Hildegard Bentele (EPP, DE), rapporteur of the report **The Future of the EU Biotechnology and Biomanufacturing Sector: Leveraging Research, Boosting Innovation, and Enhancing Competitiveness** ( [draft](https://www.europarl.europa.eu/doceo/document/ITRE-PR-768143_EN.html) released March 21, 2025).
Bringing together senior experts from the European Commission, as well as MEPs across key political groups and committees, this roundtable aimed to shed light on:
- The evolving biosecurity policy landscape within the EU and internationally
- The intersection of synthetic biology and AI—its opportunities, challenges, and the policy pathways to bolster security while maintaining Europe’s competitive edge
- Emerging risks, security challenges, and research implications, alongside proactive measures to mitigate potential threats
- The pivotal role of funding mechanisms and international collaboration in strengthening biosecurity
Following insightful panel presentations, a dynamic and t
... (truncated, 5 KB total)Resource ID:
f263f537e614f8ae | Stable ID: ZmQzZDAxYT